Achieve Life Sciences, Inc. (ACHV) stock
ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
$6.72+0.34 (+5.33%)
Close on Nov 6, 2026Market cap $708.81MP/E –Yield –
Achieve Life Sciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Achieve Life Sciences's enterprise value was $502.96M on Nov 6, 2026, against $209.10M a year earlier. Over the last 5 years it ranged from -$7.98M to $643.68M, with a median of $83.90M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 6, 2026 | $502.96M | +134.6% |
| 2025 | Dec 31, 2025 | $214.38M | +174.3% |
| 2024 | Dec 31, 2024 | $78.15M | +16.2% |
| 2023 | Dec 29, 2023 | $67.28M | +1102.7% |
| 2022 | Dec 30, 2022 | $5.59M | -86.1% |
| 2021 | Dec 31, 2021 | $40.24M | +483.1% |
| 2020 | Dec 31, 2020 | $6.90M | -91.2% |
| 2019 | Dec 31, 2019 | $78.51M | -25.5% |
| 2018 | Dec 31, 2018 | $105.41M | -96.6% |
| 2017 | Dec 29, 2017 | $3.07B | +111999.0% |
| 2016 | Dec 30, 2016 | $2.74M | – |
| 2015 | Dec 31, 2015 | -$9.68M | -143.9% |
| 2014 | Dec 31, 2014 | $22.03M | -84.8% |
| 2013 | Dec 31, 2013 | $144.59M | -32.7% |
| 2012 | Dec 31, 2012 | $214.97M | +96.6% |
| 2011 | Dec 30, 2011 | $109.32M | – |
See a number that looks wrong?